Evaluation of Peritoneal Cancer Index as a Prognostic Marker in Primary Advanced Epithelial Ovarian Carcinoma Undergoing “Interval Cytoreductive Surgery” After Neoadjuvant Chemotherapy
Journal of Gynecologic Surgery · 01.08.2021 · 37 (4) · 331-336
DOI: 10.1089/gyn.2020.0099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Surgery, erschienen am 01.08.2021. Verfasst von Babul Bansal und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bansal, B., Ray, M., Barua, A., Saikia, J., & Deo, S. (2021). Evaluation of Peritoneal Cancer Index as a Prognostic Marker in Primary Advanced Epithelial Ovarian Carcinoma Undergoing “Interval Cytoreductive Surgery” After Neoadjuvant Chemotherapy. Journal of Gynecologic Surgery, 37(4), 331-336. https://doi.org/10.1089/gyn.2020.0099
Vancouver
Bansal B, Ray M, Barua A, Saikia J, Deo S. Evaluation of Peritoneal Cancer Index as a Prognostic Marker in Primary Advanced Epithelial Ovarian Carcinoma Undergoing “Interval Cytoreductive Surgery” After Neoadjuvant Chemotherapy. Journal of Gynecologic Surgery. 2021;37(4):331-336. doi:10.1089/gyn.2020.0099
BibTeX
@article{Bansal2021,
author = {Bansal, Babul and Ray, Mukurdipi and Barua, Areendam and Saikia, Jyoutishman and Deo, Suryanarayana},
title = {Evaluation of Peritoneal Cancer Index as a Prognostic Marker in Primary Advanced Epithelial Ovarian Carcinoma Undergoing “Interval Cytoreductive Surgery” After Neoadjuvant Chemotherapy},
journal = {Journal of Gynecologic Surgery},
year = {2021},
volume = {37},
number = {4},
pages = {331--336},
doi = {10.1089/gyn.2020.0099}
}
EUVIMED